When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DEST - Destiny Pharma upbeat on prospects for C. Difficile treatment
Destination Maternity Corporation
(NewsDirect)
Destiny Pharma PLC (AIM:DEST, OTC:DTTYF)chief scientific officer Bill Love speaks to Proactive after resultsfrom a study into its C. Difficile treatment platform NTCD-M3 werepublished in the Microbiology Spectrum journal.
Love explainswhat makes the platform so promising from Destiny's point of view,before going on to reveal more about the plans for bringing NTCD-M3 tothe market.